DAFNA Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-95,290
| Closed | -$1.2M | – | 82 |
|
|
2025
Q1 | $1.2M | Buy |
95,290
+6,500
| +7% | +$81.8K | 0.34% | 51 |
|
|
2024
Q4 | $937K | Sell |
88,790
-59,504
| -40% | -$628K | 0.24% | 59 |
|
|
2024
Q3 | $2.15M | Sell |
148,294
-90,900
| -38% | -$1.32M | 0.51% | 45 |
|
|
2024
Q2 | $2.04M | Hold |
239,194
| – | – | 0.49% | 43 |
|
|
2024
Q1 | $2.44M | Sell |
239,194
-71,975
| -23% | -$736K | 0.56% | 41 |
|
|
2023
Q4 | $1.71M | Buy |
+311,169
| New | +$1.71M | 0.41% | 47 |
|